Scientist
INVESTORS
2019-04-26MMMM D, YYYY

First Quarter 2019 Results

Postponement of 'Meet Sanofi Management' event

Following the announcement on June 7, 2019 that Paul Hudson will succeed Olivier Brandicourt as Chief Executive Officer, Sanofi has decided to postpone the 'Meet Sanofi Management' event scheduled to take place on June 26. Sanofi regrets any inconvenience this may cause and intends to schedule an event in the first half of December.

Please contact the Sanofi IR team if you have any further queries related to this announcement.

At a glance

Jean-Baptiste de Chatillon
2019-06-07MMMM D, YYYY

Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer

Communication from the Board of Directors

Upcoming events

  • 2019-07-29
  • 2019-10-31
All financial results going back to 2013
FINANCIAL RESULTS

All financial results going back to 2013

Annual Report on Form 20-F 2018

Annual Report on Form 20-F 2018

Contact the Investor Relations team

54 rue La Boétie
75008 Paris FRANCE
France +33 (0)1 53 77 45 45 • ir@sanofi.com
United States +1 908 981 5560

In-depth reading

Young boy on a bicycle

New franchise Rare Blood Disorders

In 2018, Sanofi created a leading platform in Rare Blood Disorders through a series of three strategic deals: we obtained global rights for fitusiran, acquired Bioverativ and Ablynx. These operations should expand Sanofi’s presence in Specialty Care and further strengthen our Research & Development pipeline.
Digital factory

The digital revolution

2017 Integrated Report

2018 Integrated Report

Scientist
FINANCIAL RESULTS

2018 sales reflecting 2019 GBU structure

2019-02-07MMMM D, YYYY
INVESTOR PRESENTATIONS

IR conference call on Odyssey Outcomes

2018-03-10MMMM D, YYYY

Individual shareholders

Direct access to Individual shareholders - Welcome to Sanofi

Access your dedicated section

Shareholder Handbook 2019

Two Asian women

Letter to shareholders March 2019

Sanofi IR app on different devices

SANOFI IR The Investor Relations app

SANOFI IR provides financial information with direct access to key news, events, publications and a dedicated section for individual shareholders
Download the IR app on the App Store Get the IR app on Google Play